Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, and high blood pressure. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada. Cell MedX Corp. is a subsidiary of Wisdom Homes of America, Inc.
Industry, Sector and Symbol
Industry Conglomerates
Sub-IndustryN/A
SectorConglomerates
Phone+1-310-5089398
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Cell MedX (OTCMKTS:CMXC) Frequently Asked Questions
What is Cell MedX's stock symbol?
Cell MedX trades on the OTCMKTS under the ticker symbol "CMXC."
Has Cell MedX been receiving favorable news coverage?
News headlines about CMXC stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cell MedX earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Cell MedX.
Who are some of Cell MedX's key competitors?
Some companies that are related to Cell MedX include 3 Sixty Risk Solutions (PTVYF), 8i Enterprises Acquisition (JFKKU), Acamar Partners Acquisition (ACAMU), Acquired Sales (AQSP), Act II Global Acquisition (ACTTU), AGBA Acquisition (AGBAU), Alberton Acquisition Corporation Units (ALACU), Allegro Merger Corp. Units (ALGRU), Alterola Biotech (ALTA), AMCI Acquisition Corp. Units (AMCIU), Andina Acquisition Corp. III (SAMAU), Apex Technology Acquisition (APXTU), ARYA Sciences Acquisition Corp. Units (ARYAU), BARINGTON / HIL/SH (BHAC) and BIDVEST GRP LTD/S (BDVSY).
What other stocks do shareholders of Cell MedX own?
Who are Cell MedX's key executives?
Cell MedX's management team includes the folowing people:
- Mr. Frank E. McEnulty, CEO & Director (Age 63)
- Ms. Yanika Silina C.M.A., CPA, CFO, Treasurer, Corp. Sec. & Director (Age 41)
- Mr. Bradley S. Hargreaves, VP of Technology & Operations and Director (Age 60)
How do I buy shares of Cell MedX?
Shares of CMXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cell MedX's stock price today?
One share of CMXC stock can currently be purchased for approximately $0.54.
What is Cell MedX's official website?
How can I contact Cell MedX?
Cell MedX's mailing address is 123 W Nye Ln Ste 446, CARSON CITY, NV 89706-0899, United States. The company can be reached via phone at +1-310-5089398.
MarketBeat Community Rating for Cell MedX (OTCMKTS CMXC)
MarketBeat's community ratings are surveys of what our community members think about Cell MedX and other stocks. Vote "Outperform" if you believe CMXC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMXC will underperform the S&P 500 over the long term. You may vote once every thirty days.
